ID   A904L-CD80
AC   CVCL_A5AM
DR   Wikidata; Q107113341
RX   PubMed=11267941;
RX   PubMed=15994973;
CC   Population: Chinese; Han and Korean.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1700; CD80.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U095 ! A904L
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
RX   PubMed=11267941; DOI=10.1111/j.1349-7006.2001.tb01096.x; PMCID=PMC5926714;
RA   Takenoyama M., Yoshino I., Eifuku R., So T., Imahayashi S., Sugaya M.,
RA   Yasuda M., Inoue M., Ichiyoshi Y., Osaki T., Nagashima A., Nomoto K.,
RA   Yasumoto K.;
RT   "Successful induction of tumor-specific cytotoxic T lymphocytes from
RT   patients with non-small cell lung cancer using CD80-transfected
RT   autologous tumor cells.";
RL   Jpn. J. Cancer Res. 92:309-315(2001).
//
RX   PubMed=15994973; DOI=10.1158/0008-5472.CAN-04-3787;
RA   So T., Takenoyama M., Mizukami M., Ichiki Y., Sugaya M., Hanagiri T.,
RA   Sugio K., Yasumoto K.;
RT   "Haplotype loss of HLA class I antigen as an escape mechanism from
RT   immune attack in lung cancer.";
RL   Cancer Res. 65:5945-5952(2005).
//